A Study of MGC026 in Participants With Advanced Solid Tumors
Conditions
Advanced Solid Tumor · Advanced Cancer · Metastatic Cancer · Squamous Cell Carcinoma of Head and Neck · Non Small Cell Lung Cancer · Small-cell Lung Cancer · Bladder Cancer · Sarcoma · Endometrial Cancer · Melanoma · Castration Resistant Prostatic Cancer · Cervical Cancer · Colorectal Cancer · Gastric Cancer · Gastro-esophageal Cancer · Pancreas Cancer · Clear Cell Renal Cell Carcinoma · Hepatocellular Carcinoma · Platinum-resistant Ovarian Cancer · Breast Cancer · Ovarian Cancer · Esophageal Squamous Cell Cancer (SCC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The Angeles Clinic and Research Institute, Los Angeles, California, United States
START Midwest, Grand Rapids, Michigan, United States
START-New York Long Island, Lake Success, New York, United States
Providence Cancer Institute, Portland, Oregon, United States
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
University of Texas Health Science Center at Houston, Houston, Texas, United States
START Mountain Region, West Valley City, Utah, United States
ICON Cancer Centre Wesley, Auchenflower, Queensland, Australia
ICON Cancer Centre Kurralta Park, Kurralta Park, South Australia, Australia
Austin Health- Olivia Newton John Cancer Center, Heidelberg, Victoria, Australia
Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
Study leads
Denise Casey, MD
Study Director
MacroGenics